Current status and prospect of neoplasm targeted therapy.
- Author:
Yan WANG
1
;
Yan SUN
Author Information
1. Department of Internal Medicine, Oncology Hospital, Institute of Oncology, China Union Medical University, Chinese Academy of Medical Sciences, Beijing 100021, China
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
administration & dosage;
Antibodies, Monoclonal, Humanized;
Antineoplastic Agents;
administration & dosage;
Benzamides;
Cetuximab;
Drug Delivery Systems;
methods;
Drug Design;
Erlotinib Hydrochloride;
Humans;
Imatinib Mesylate;
Immunologic Factors;
administration & dosage;
Neoplasms;
drug therapy;
Palliative Care;
methods;
Piperazines;
administration & dosage;
Pyrimidines;
administration & dosage;
Quinazolines;
administration & dosage;
Signal Transduction
- From:
Chinese Journal of Oncology
2005;27(10):638-640
- CountryChina
- Language:Chinese
